Depression and anxiety arise from a combination of disrupted chemical signaling, overactive threat-detection circuits, chronic stress hormones, brain inflammation, and altered patterns of neural connectivity. There is no single “chemical imbalance” that explains either condition. Instead, multiple biological systems interact, and when several go wrong at once, the result is the persistent low mood, worry, and emotional dysregulation that define these disorders.
Chemical Messengers Out of Balance
Your brain relies on chemical messengers to relay signals between neurons. Four of these play especially important roles in mood and anxiety: serotonin, dopamine, GABA, and glutamate. Serotonin helps regulate mood, sleep, and appetite. Dopamine drives motivation and the experience of reward. These two get the most public attention, but the balance between the other pair, GABA and glutamate, may matter just as much.
GABA is the brain’s primary calming signal. It slows neural activity down. Glutamate does the opposite: it’s the brain’s chief excitatory signal, ramping activity up. Anxiety is thought to stem from an imbalance between these two systems, with too much excitation relative to inhibition. People with social anxiety, for example, have been found to have roughly 13% higher glutamate levels in a key brain region called the anterior cingulate cortex compared to people without anxiety, and the higher those levels, the worse their symptoms.
Altered glutamate levels have also been found in the plasma, spinal fluid, and brain tissue of people with depression. Because glutamate is the raw material the brain uses to make GABA, disruptions in one system ripple into the other. This is why the old idea of depression as simply “low serotonin” has given way to a more complex picture involving multiple chemical systems that influence each other.
The Stress System Gets Stuck
When you face a threat, your brain activates what’s known as the HPA axis: a signaling chain that starts in the brain and ends with cortisol flooding your bloodstream. Cortisol is useful in short bursts. It sharpens focus, raises blood sugar, and prepares the body to respond. The problem comes when this system stays switched on.
Cortisol binds to receptors throughout the brain, with especially high concentrations in the hippocampus, a structure critical for memory and emotional regulation. Under chronic stress, sustained cortisol exposure can damage these receptors, weakening the brain’s ability to shut the stress response off. The result is a feedback loop: stress raises cortisol, cortisol impairs the brain’s off-switch, and the stress response stays elevated. This dysregulation of cortisol receptors in the HPA axis has been directly linked to the development of major depression.
Brain Structures That Shrink or Overfire
Two structures sit at the heart of both conditions: the amygdala and the hippocampus. The amygdala processes threats and emotional reactions. The hippocampus helps form memories and regulate emotions. In depression and anxiety, these structures behave abnormally.
In people with depression, the amygdala shows increased activity at rest, during sleep, and in response to emotional triggers like fearful faces, sad images, or negative pictures. It essentially overreacts to the emotional content of everyday experience, amplifying negative feelings beyond what the situation warrants. This heightened reactivity has been observed consistently across multiple types of brain imaging studies.
The hippocampus tells a different story. A large and highly consistent body of research shows that people with depression have reduced hippocampal volume, and the shrinkage correlates with the number and duration of depressive episodes. Longer or more frequent bouts of depression are associated with more pronounced volume loss. Because the hippocampus is where cortisol receptors are most concentrated, this shrinkage likely reflects the cumulative damage of chronic stress hormone exposure, creating yet another self-reinforcing cycle.
Meanwhile, the prefrontal cortex, which normally helps regulate emotional responses by keeping the amygdala in check, shows reduced function in depression. The result is a brain where the emotional alarm system is overactive and the rational control system is underperforming.
Inflammation That Reaches the Brain
One of the most important discoveries in recent decades is that depression and anxiety involve the immune system. People with depression consistently show higher blood levels of inflammatory molecules, particularly three: IL-1β, IL-6, and TNF-α. They also show lower levels of anti-inflammatory molecules. This isn’t a subtle shift. In animal studies modeling social stress, vulnerable animals had IL-6 levels 27 times higher than resilient ones. When researchers blocked IL-6 with an antibody before exposing animals to the same stress, the animals didn’t develop depressive behaviors, strongly suggesting that inflammation isn’t just a byproduct of depression but actively contributes to it.
These inflammatory molecules don’t stay in the bloodstream. They cross the blood-brain barrier, sometimes by physically weakening it. Researchers have found that stressed animals show reduced levels of a key protein that holds blood-brain barrier cells together, essentially creating gaps that let inflammatory molecules into brain tissue. Once inside, these molecules activate the brain’s own immune cells, which release even more inflammatory signals. This chain reaction disrupts neurotransmitter balance directly. IL-6, for instance, has been shown to reduce GABA’s calming activity in brain tissue, tipping the balance toward the kind of neural hyperexcitability associated with anxiety.
Growth Factors and the Brain’s Ability to Adapt
Healthy brains constantly remodel themselves, strengthening useful connections and pruning unused ones. A protein called BDNF (brain-derived neurotrophic factor) is central to this process. BDNF promotes the survival of existing neurons, encourages the growth of new connections, and strengthens the signaling at synapses, the junctions where neurons communicate.
In depression, BDNF levels drop. This matters because BDNF is essential for a process called long-term potentiation, which is how the brain encodes learning and adapts to new experiences. Without adequate BDNF, synapses weaken, dendritic spines (the tiny protrusions that receive signals from other neurons) fail to grow and stabilize, and the hippocampus loses its capacity to generate new neurons. The brain becomes less flexible, less able to adapt to changing circumstances, and less able to recover from negative experiences. This reduced plasticity is now considered a core feature of depression rather than a side effect.
This also helps explain why antidepressant medications take weeks to work. Their immediate effect is to increase the availability of serotonin or other chemical messengers in the synapse. But the therapeutic benefit appears to depend on a slower cascade of changes: receptor adjustments that develop over days to weeks, followed by increases in BDNF, dendritic growth, new synapse formation, and the gradual restoration of neural flexibility. The drug’s real job, in other words, isn’t just to boost a chemical but to restart the brain’s capacity to remodel itself.
Neural Networks and Rumination
Beyond individual brain regions, depression involves disrupted communication between networks. One of the most studied is the default mode network (DMN), a set of brain regions that activates when you’re not focused on the external world: daydreaming, reflecting on yourself, thinking about the past or future. In healthy brains, the DMN turns on during downtime and turns off when you need to focus outward.
In depression, the DMN becomes abnormally connected to a region called the subgenual prefrontal cortex, an area associated with negative emotions and behavioral withdrawal. Interestingly, the DMN itself doesn’t appear to be overactive in depression. Instead, its normal self-reflective processes become fused with the emotional withdrawal signals from the subgenual prefrontal cortex. The result is rumination: a loop of self-focused, negatively charged thinking that feels impossible to break. This abnormal connectivity reliably predicts how much rumination a person experiences.
Depression and anxiety also share disruptions in broader prefrontal circuits, including the salience network (which decides what deserves your attention) and the frontoparietal network (which supports focused thinking and decision-making). These overlapping network disruptions help explain why the two conditions co-occur so frequently.
Why Depression and Anxiety So Often Overlap
Roughly half of people diagnosed with one condition also meet criteria for the other. This isn’t coincidence. The shared biology runs deep: the same stress hormone pathways, the same inflammatory molecules, the same prefrontal and limbic circuits, and the same reductions in neural plasticity contribute to both. Twin studies confirm this overlap at the genetic level. The heritability of depression alone is about 50%, and for anxiety alone about 41%. But when both conditions occur together, heritability jumps to 79%, meaning the genetic contribution to the combined condition is substantially greater than for either one in isolation.
The current diagnostic system reflects this complexity. The DSM-5 includes an “anxious distress” specifier for depression, recognizing that symptoms like feeling tense, unusually restless, or unable to concentrate due to worry frequently accompany depressive episodes. No clear clinical guideline yet distinguishes depression with anxiety features from anxiety that has triggered depression. At the level of brain biology, the distinction may be less meaningful than it appears on paper, because the underlying circuits are so deeply intertwined.